aclidinium bromide; formoterol fumarate · Azurity · NDA 210595
Duaklir Pressair
Earliest generic entry, as listed
13 Mar 2029
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 10085974, US 11000517.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10085974 | drug product, use U-2513 · sets the listed date | 13 Mar 2029 |
| US 11000517 | drug product, use U-2513 · sets the listed date | 13 Mar 2029 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 210595 · 001 · RLD · discontinued | powder, metered, inhalation | 0.4MG/INH;0.012MG/INH | 13 Mar 2029 |